US Government Signs $2-Billion Deal for 100-Million Doses of COVID Vaccine Never Tested for Safety

Pixabay
The US signed a $1.95 billion agreement with pharma giant Pfizer and Germany’s BioNTech for 100-million doses of their experimental COVID-19 vaccine that Americans will be told to accept early next year. RNA vaccines have never received regulatory approval because they never have been tested for safety of efficacy. A vaccine trial involving 30,000 healthy volunteers may happen later this month – but the money has been approved anyway as though those making the deal already know the tests will not be allowed to fail – no matter the results. The government also signed other experimental vaccine deals, including a $1.6-billion contract with Novavax for 100-million doses, $1.2-billion for AstraZeneca’s new vaccine, $456-million for Johnson & Johnson’s new vaccine; $486-million for Moderna’s experimental vaccine; and $6-million for Emergent Biosolutions’ vaccine.

An estimated 30% of Americans have said they will reject the vaccine. Trump said he will accept the vaccine. He mentioned that he knew several people who died from coronavirus, but he also admitted they were older and had other potentially fatal health problems. Trump said he “almost” prefers therapeutic drugs over vaccines but stands on his pledge to use the military to force the acceptance of vaccines as soon as they are available. -GEG

The United States on on Tuesday signed a $1.95 billion agreement with US pharma giant Pfizer and Germany’s BioNTech for 100 million doses of their experimental COVID-19 vaccine, part of an aggressive push to start immunizing Americans early next year.

It is the biggest deal to date under Operation Warp Speed, intended to accelerate the development, manufacturing, and distribution of coronavirus vaccines, therapeutics, and diagnostics.

Pfizer and BioNTech, which are developing the drug together, said in statements that the American people would receive the future vaccine “for free” in line with the Trump administration’s pledge.

 

Under the agreement, the US government has placed an initial order for 100 million doses to be delivered if regulatory approval is granted.

The US government also has an option to purchase as many as 500 million additional doses from the two firms.

BioNTech and Pfizer have narrowed their vaccine candidates down to two frontrunners and are waiting for the green light to begin a mass trial involving 30,000 healthy volunteers, which may happen later this month.

If the studies are successful, they expect to receive some form of emergency approval as early as October 2020.

Earlier this month, they announced that early results showed their lead candidate produced neutralizing antibodies in humans at or above the levels observed in recovered COVID-19 patients.

This was accomplished with relatively low doses and caused side effects that were mild to moderate but transient, which is considered normal.

“We are assembling a portfolio of vaccines to increase the odds that the American people will have at least one safe, effective vaccine as soon as the end of this year,” said health secretary Alex Azar of the deal.

“We are honored to be a part of this effort to provide Americans access to protection from this deadly virus,” added Albert Bourla, chairman and CEO of Pfizer.

– Vaccine race –

Labs around the world are racing to produce a vaccine to help end the worst health crisis in over a century.

More than 200 candidate vaccines are currently being developed with roughly two dozen at the stage of clinical trials with human volunteers.

Earlier this month, the US signed a $1.6 billion deal with Novavax for 100 million doses.

In May, the government announced up to $1.2 billion for AstraZeneca’s candidate vaccine, developed in conjunction with the University of Oxford.

The US has also announced $456 million for Johnson & Johnson’s vaccine candidate; $486 million for Moderna’s; and $628 million for Emergent Biosolutions.

The government is likewise investing in manufacturing capacity at its own risk, and spending hundreds of millions in companies that produce syringes, vials and medical glass-coated plastic containers.

– RNA vaccine –

The Pfizer-BioNTech vaccine method relies on using messenger RNA, genetic code from the SARS-CoV-2 that slips into human cells to produce a synthetic form of the virus’ spike protein.


Read full article here…

Visit our Classified ads.

Check out our Classified ads at the bottom of this page.

Recent stories & commentary

Classified Ads

The appearance of ads on this site does not signify endorsement by the publisher. We cannot vouch for accuracy of statements or integrity of advertisers. We will investigate complaints, however, and remove any message we find to be misleading or that promotes anything fraudulent or unethical.
For ad rates, click here.

Subscribe
Notify of
guest
4 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
Ed
Ed
3 years ago

I don’t THINK that even Trump can save this nation from the deep SNAKES burrowed into washinton DC. Another STUMULUS PKG. ? ? ? ? That will collapse the entire financial system. They have Trump surrounded by the CFR, Soros’ control, and the communists of America. Be ready for REAL hard times.

Gourdhead
Gourdhead
3 years ago
Reply to  Ed

I fear you are right.

Caspar de Rijk
Caspar de Rijk
3 years ago

When and where did Trump pledge to use the military to force vaccination? It’s not in the video. And I remember having heard him say that he would support free choice in the matter of vaccination.

Paul
Paul
3 years ago
Reply to  Caspar de Rijk

Why use the military at all? Sounds ominous to me. Trump’s legal advisor in the impeachment trial (Dershowitz) – obviously someone Trump listens to – stated back in May that “forced coronavirus vaccinations could happen”. He then elaborated:
“And if you refuse to be vaccinated, the state has the power to literally take you to a doctor’s office and plunge a needle into your arm,” he added.